multiple warning signs along the way. interview after interview, talking about hypotheticals. No significant data produced, Yuman Fong re-enforcing the hypothetical and results from petri-dish.
they had to pivot to new products I.e. Azer Cel, why pivot and waste money, when the narrative was that they had the holy grail in CF33. They’re literally fumbling their way through, with nothing of substance on the table.
capital management has been appalling because they’re buying drugs that aren’t living up to the pre-clinical hype.
if CF33 and Azer Cel were as good as they say, why didn’t big pharma snap them up, instead of Hopper and his crew lol.
why would anyone give these incompetent mob a cent?? Mind boggling.
before any of the die hard fans attack, look at the share price, as this clearly illustrates these points.
and “No”, the market does not get the value wrong, the market is right. Because their currently is nothing to value it higher.
where is this beautiful data???
IMU Price at posting:
1.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)